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Abstract  
Natural remedies from medicinal plants are considered to be effective and safe alternative treatment for liver toxicity. The 
article reveals the hepatoprotective activity of the ethanolic extract of the roots of the Citrullus colocynthis in rats using carbon 
tetrachloride (CCl4) model. On further fractionation of the ethanolic extract into three fractions, the activity was localized in the 
toluene fraction. These on purification led to the isolation of 2 pure compounds – Cucurbitacin B [1] and Colocynthin [2]. 
These two compounds showed promising activity in CCl4 model at 50 mg/kg dose level.  
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INTRODUCTION 
Liver regulates various important metabolic functions. Hepatic 
damage is associated with distortion of these metabolic functions. 
Liver diseases such as cirrhosis, fatty liver and chronic hepatitis are 
important world health issues. Conventional and synthetic drugs 
used in liver disease are inadequate and sometimes have serious 
side effects.(Luper;1998) The use of herbal remedies for the 
treatment of liver diseases has long history starting with Ayurvedic 
treatment and extending to the Chinese, European and other 
systems of traditional medicine. A large number of plants and 
formulations have been claimed to have hepatoprotective effect. 
Some plants which have shown genuine utility in liver disorders are 
Silybium marinum, (Ram;2001) Picrrorhiza kurroa, (Thyagarajan; 
2002) Andographis paniculata, Phyllunthus niruri and Eclipta 
alba.(Bisset;1994).  
Citrullus colocynthis L. sch. (Cucurbitaceae) commonly known 
as indrayan widely cultivated throughout the India and Saudi Arabia 
(Kirtikar and Basu, 1975). The plant is very precious for Indian 
system of medicine particularly Ayurveda and Siddha. The leaves 
are diuretic and used in treatment of Jaundice and asthma. (Chadha; 
1950). The fruit is purgative anthelmintic, antiepileptic, molluscicide 
and insecticide, and is used against gonorrhea (Yahya-AL, et al; 
2000). Plant contains cucurbitacins A, B, C, D and α-elaterin which is 
the important constituents used for the treatment of hepatic ailments 
(Wallis, 2005). The drug exhibited anti-inflammatory, antidiabetic, 
and antispermatogenic activities. (Abdel Hassan et al; 2000, Moli, 
2001). The plant is also useful in the treatment of liver disorder with 
others herbs in different traditional medicine. The aim of the present 
investigation is to justify the traditional claim by investigation its use 
in hepatic disorders.  
MATERIAL AND METHODS 
Collection and Identification of Plant 
The plant material was purchased from the local market 
Lucknow and authenticated by a Taxonomist in National Botanical 
Research Institute (NBRI) Lucknow.  The voucher specimen No. 
LWG-224812 was deposited in the departmental herbarium of NBRI 
Lucknow, India for future reference.  
Extraction/fractionation/isolation procedure 
The  roots  of the  plant  (2.0 kg) were air  shade  dried  
and  powdered  after  collection. The powdered   plant   
material   was extracted   with petroleum ether (60°-80°C) for 
defatation. The defatted powdered drugs were then extracted with 
95% ethanol  (3 x 3 L) at room temperature. The combined extracts 
were evaporated in a rotary evaporator below 50oC to a brown mass, 
which was further dried under high vacuum (24.54% w/w). A part of  
the  ethanol   extract  thus  obtained   was  fractionated  
into  three  fractions  toluene soluble fraction (CC- I), chloroform 
soluble fraction (CC-II) and ethyl acetate soluble fraction(CC-III). In 
the separate study different fractions of the plant were then 
subjected to hepatoprotective activity to identify the most active 
fraction against CCl4 induced toxicity. The hepatoprotective activity 
was Localized significantly in  toluene  fraction (CC-I).  This 
fraction was therefore purified by chromatography over silica gel 
separately and three compounds were isolated. Out of the three 
compounds, only two,  i.e.  Comp.-I and Comp.-II, were separated 
with dark absorbing spot and blue fluorescent spot and identified as 
Cucurbitacin-B [1] and Colocynthin [2]. These compounds were also 
subjected for the hepatoprotective evaluation. 
Hepatoprotective activity of plant extract, fraction and isolated 
compounds against CCl4  model      
Albino rats (150-200g) of either sex were selected for study. 
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Animals were kept in polypropylene cages for 3-4 days under 
standard experimental conditions before the experiment.  Animals 
were given standard pellet diet and fresh drinking water ad libitum. 
The study protocol was approved by the Institutional Animal Ethics 
Committee of Central Drug Research Institute (CDRI), Lucknow 
The effect of extract, fractions and isolated compounds of the 
plant on carbon tetra chloride (CCl4) induced toxicity in rats were 
studied. Rats were divided into different groups including control, 
toxin, tests groups and standard with 6 animals in each group. The 
rats of control group (I) received 5% w/w acacia suspension. The 
toxin group (II) was treated with one dose of toxin (CCl4 2.5ml/kg 
p.o.) in olive oil mixture (1:1) (Kurma and Mishra, 1997). Test groups 
treated with doses (100 mg/kg b.w., p.o.) ethanolic extract, toluene 
soluble fraction, chloroform soluble fraction, ethyl acetate soluble 
fraction in 5% w/w acacia suspension at 12 hrs interval and toxin 
(CCl4) one hour after the last dose (Janbaz and Gilani, 2000) and 
both isolated compounds with doses of 50 mg/kg b.w. p.o. Silymarin 
used as standard with a dose of 25 mg/kg p.o.  (Bhattacharyya et al, 
2003). Animals were anaesthetized by light ether anesthesia and the 
blood was withdrawn by reterorbital plexus puncture. It was allowed 
to coagulate for 30 minutes in tubes and serum was separated by 
centrifugation at 2500 rpm. The serum was used to estimate Serum 
Glutamate Pyruvate Transaminase (SGPT), Serum Glutamate 
Oxaloacetate Transaminase (SGOT), Alkaline Phosphatase (ALP), 
Total Bilirubin (BL). Percent reduction of biochemical parameters 
was calculated by following equation. 
 
        AUC Toxin control – AUC treatment  
% Reduction =                         X 100 
RESULTS AND DISCUSSION 
 
     The  ethanol  extract  of the  roots  of the  C. 
colocynthis  showed  promising antihepatotoxic   activity  
(reduction in biochemical parameters) at  100 mg/ kg   dose  
level  (SGOT 48.49%, SGPT 51.30%, ALP 76.85%, BL %)  in 
experimental  rats.  On  further  fractionation the  toluene 
fraction and chloroform fraction  showed  activity (SGOT 51.52%, 
37.44%, SGPT 59.35%, 50.33%,  ALP 78.67%, 72.87%, BL 
79.31%, 70.69%) respectively   at  100 mg/kg   dose,  while  
ethyl acetate fraction   showed activity  (SGOT 40.86%, SGPT 
53.92%, ALP 75.10%,  BL 72.41%)  at  100 mg/kg  dose level. 
The  pure  compounds isolated  from  toluene  fractions are 
cucurbitacin B [1] (SGOT 68.09%, SGPT 63.64%, ALP 76.81%, BL 
68.22%)  and colocynthin [2]  (SGOT 71.28%, SGPT 65.24%, 
ALP 80.68%, BL 54.92%)  were found active in CCl4 model at 50 
mg/ kg  dose whereas drug silymarin showed reduction as (SGOT 
79.73%, SGPT 74.26%, ALP 87.88%,BL 82.75% ) at 25 mg/kg dose 
level. The protective effect can be confirmed by enzymatic and non-
enzymatic comparative performance which resulted in a marked 
reduction of serum GOT, GPT, ALP and BL levels. To sum up the 
above discussion, altogether it is proved that C. colocynthis extract, 
fractions and isolated compound could inhibit CCl4 induced hepatitis 
by regulating various biochemical parameters such SGPT, SGOT, 
ALP and BL and liver metabolites. These data are required not only 
for identification procedures that guarantee the utilization of the 
appropriate raw material, but also for quality-control standards 
demanded by health legislation.  
                   AUC control    
 
Table 1. Hepatoprotective activity the extract/fractions/pure compounds of the C. colocynthis 
 
 
 
Each group contains 6 animals. Values in parenthesis indicate percentage recovery. All groups were compared to toxic control by students-Newman-Keuls-test(a P<0.001) 
 
 
 
 
 
Extracts/fractions/ 
compounds 
Dose mg/kg  (%Reduction)  
SGOT 
(U/ml) 
SGPT (U/ml)     ALP                  BL 
    (U/L)         (mg/dL) 
 
Control group 1ml 29.52±1.78 a 15.03±2.30 a 4.45±0.42 a 0.24±0.02a 
Toxin group 2.5ml 114.01±8.82 77.52±9.26 18.52±0.64 4.06±0.14 
Ethanolic extract 100 38.19±2.50 (89.73) 47.45±5.96 (48.11) 11.54±0.45 (49.60) 1.32±0.15 
(71.72) 
Toluene soluble fraction 100 85.42±2.13 (68.6) 39.61±0.59 (91.1) 29.37±2.36 (59.7) 0.84±0.15 
(77.1) 
Chloroform soluble fraction 100 112.41±4.22 (48.2) 48.40±4.24 (77.2) 41.28±2.45 (24.9) 1.19±0.07 
(59.3) 
Ethyl acetate soluble fraction 100 104.20±4.87 (54.4) 44.90±3.05 (82.8) 34.41±2.43 
(45.0) 
1.12±0.03 
(62.9) 
Cucurbitacin B (1) 50 35.61±2.36 
(88.6) 
68.47±4.05 
(92.2) 
28.10±1.60 
(61.4) 
1.29±0.22 
(82.2) 
Colocynthin (2) 50 38.11±3.12 
(84.4) 
71.32±3.16 
(89.5) 
26.42±2.65 
(68.0) 
1.96±0.45 
(66.5) 
Standard (Silymarin) 25 79.77±2.98 (72.9) 44.59±2.28 
(83.2) 
27.62±1.70 (64.8) 0.70±0.05 
(84.2) 
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Figure 1 (a) Chemical structure of compound cucurbitacin B [1] 
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Figure 1 (b) Chemical structure of compound colocynthin [2] 
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